The Production of Therapeutic Proteins in Plants: Apo AI and Insulin
The Production of Therapeutic Proteins in Plants: Apo AI and Insulin The Production of Therapeutic Proteins in Plants: Apo AI and Insulin
SemBioSys’ NicheSemBioSys focuses on finding existing protein based drugsof therapeutic interest or other products such as specialty oilsfor which there is an unmet need.SemBioSys addresses demand/protein availability issueswith a lower cost production system. SemBioSys is aplatform technology company.
SemBioSys’ TechnologyProof-of-ConceptArabidopsis thalianaCommercial Production SpeciesSafflower (Carthamus tinctorius)
- Page 1 and 2: The Production of Therapeutic Prote
- Page 3: SemBioSys OverviewLocation: Calgary
- Page 7 and 8: Field Grown GMO SafflowerPlanting s
- Page 9 and 10: Purification of OilbodiesThe Proces
- Page 11 and 12: Plant Impurity AssaysPhytate (IP 6
- Page 13 and 14: Product Impurity Assays - Fusion Pa
- Page 15 and 16: Viral Load/Viral ClearanceRegulator
- Page 17 and 18: InsulinPositioned to Meet the Growi
- Page 19 and 20: Economics of Plant-Produced Insulin
- Page 21 and 22: Insulin - Equivalence DataV8 Protea
- Page 23 and 24: Insulin - Equivalence DataIGF-1 Rec
- Page 25 and 26: Insulin Characterization: Clinical
- Page 27 and 28: Apo AI Milano (SBS-2000)• FTO - S
- Page 29 and 30: Functional Characterization of Puri
- Page 31 and 32: Cholesterol Mobilization in vivoSBS
- Page 33: Non-Pharma ProductsProducts and Com
SemBioSys’ NicheSemBioSys focuses on f<strong>in</strong>d<strong>in</strong>g exist<strong>in</strong>g prote<strong>in</strong> based drugs<strong>of</strong> therapeutic <strong>in</strong>terest or other products such as specialty oilsfor which there is an unmet need.SemBioSys addresses dem<strong>and</strong>/prote<strong>in</strong> availability issueswith a lower cost production system. SemBioSys is aplatform technology company.